The Effect of Famotidine on autistic disorder

The Effect of Famotidine on symptom of autistic spectrum disorder

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20200115046137N4

Enrollment

Registered

2024-11-17

Start date

2024-11-21

Completion date

Unknown

Last updated

2025-01-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism. Autistic disorder

Interventions

Intervention 1: Intervention group: In this group, along with the continuation of autism treatments, the children will be given Famotidine at a dose of 1.5 mg/kg/day for three months. The available fo

Eligibility

Sex/Gender

All

Age

2 Years to 16 Years

Inclusion criteria

Inclusion criteria: Presence of autism spectrum disorders in the patient Parental satisfaction and adherence to the treatment medicine age (2 years -16 years)

Exclusion criteria

Exclusion criteria: Parents' dissatisfaction Having digestive problems Having other known neurological disorders

Design outcomes

Primary

Measure	Time frame
Autism severity. Timepoint: Initiation of the study, 3 months after the intervention. Method of measurement: M-Chat-RF questionnaire.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Shahram Sadeghvand

Tabriz University of Medical Sciences

shahram.sadeghvand@yahoo.com+98 41 3159 5050

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026